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ABSTRACT Leukocytes roll along the endothelium of
postcapillary venules in response to inf lammatory signals.
Rolling under the hydrodynamic drag forces of blood flow is
mediated by the interaction between selectins and their li-
gands across the leukocyte and endothelial cell surfaces. Here
we present force-spectroscopy experiments on single com-
plexes of P-selectin and P-selectin glycoprotein ligand-1 by
atomic force microscopy to determine the intrinsic molecular
properties of this dynamic adhesion process. By modeling
intermolecular and intramolecular forces as well as the ad-
hesion probability in atomic force microscopy experiments we
gain information on rupture forces, elasticity, and kinetics of
the P-selectinyP-selectin glycoprotein ligand-1 interaction.
The complexes are able to withstand forces up to 165 pN and
show a chain-like elasticity with a molecular spring constant
of 5.3 pN nm21 and a persistence length of 0.35 nm. The
dissociation constant (off-rate) varies over three orders of
magnitude from 0.02 s21 under zero force up to 15 s21 under
external applied forces. Rupture force and lifetime of the
complexes are not constant, but directly depend on the applied
force per unit time, which is a product of the intrinsic
molecular elasticity and the external pulling velocity. The high
strength of binding combined with force-dependent rate con-
stants and high molecular elasticity are tailored to support
physiological leukocyte rolling.
Adhesive interactions between cells play a central role in the
function of the immune system. Unique among the cell–cell
interactions of the immune system is the rolling of leukocytes
on activated endothelium. This rolling under hydrodynamic
shear forces is a first step in directing leukocytes out of the
blood stream into sites of inflammation and is mediated by the
selectins, a family of extended, modular, and calcium-
dependent lectin receptors (1, 2). To fulfill their physiological
function, the selectins and their ligands exhibit a unique
combination of mechanical and biochemical properties. They
associate very fast and with high affinity and can tether cells
over distances of up to 100 nm by their long, chainlike
structure. The selectin-ligand complexes withstand high tensile
forces and terminate their binding in a controlled way to
maintain rolling without themselves being pulled out of the cell
membrane.
P-selectin, located on the endothelial cell wall, supports
leukocyte rolling under hydrodynamic flow via interactions
with its glycoprotein counterligand P-selectin glycoprotein
ligand-1 (PSGL-1) expressed on microvilli of the leukocyte
surface (2). P-selectinyPSGL-1 binding involves interacting
sites that are located close to the amino-terminal portion of
each molecule and furthest away from the cellular membrane
(2). Both molecules are well characterized (2–6) and provide
a prototypic system to study the kinetics and mechanics of
adhesion processes at the molecular level. Here we have used
recombinant proteins consisting of the extracellular portions
of P-selectin and PSGL-1 expressed as chimeras with the
human IgG1 constant region. To bind P-selectin, PSGL-1
requires several posttranslational modifications (3, 5), includ-
ing appropriate terminal glycosylation containing the fucosy-
lated and sialylated tetrasaccharide sialyl Lewisx (sLex) (7, 8).
We show here that PSGL-1 expressed in 293 cells transfected
with fucosyl transferase III (FTIII) (9) is fully functional and
binds P-selectin with an affinity similar to the natural ligand.
We investigated the interaction of P-selectin with PSGL-1
under defined external forces by using atomic force microscopy
(AFM) and directly measured the mechanical properties of
single complexes. In AFM force-spectroscopy experiments,
ligand molecules are immobilized on the tip of an AFM
cantilever and their corresponding receptors on a counter
surface. The AFM sensor is approached toward the surface
where the molecules can bind and subsequently is retracted at
a constant pulling velocity. By monitoring the cantilever
deflection during such an approach-retraction cycle the bind-
ing, stretching, and rupture of receptoryligand complexes can
be investigated in terms of forces (10–16). As illustrated in Fig.
1, AFM simulates the binding, stretching, and unbinding of
receptoryligand complexes under rolling conditions. Recent
theoretical considerations show that rupture forces in such
experiments should depend on the pulling velocity of the force
sensor (17). Here we present experimental data and some
simple models on the velocity dependence of the AFM adhe-
sion probability and rupture forces of a receptoryligand system
and we discuss their relation to kinetic and thermodynamic
data obtained from standard biochemical assays.
MATERIALS AND METHODS
Production of Recombinant P-SelectinyIgG. The cDNA for
human P-selectin (18) up to and including the sixth comple-
ment repeat domain was isolated by PCR from a human lung
lambda cDNA library (CLONTECH) by using primers Psel1
(GGT AAA TGC GGC CGC ACC ATG GCC AAC TGC
CAA ATA GCC ATC) and Psel5 (GGC CTC TCA CCA ACT
TTC TTG TCC ACT TCA CAC ATT GGT GGG GAG TCT
GTC). Both primers have 59 extensions containing either the
restriction endonuclease recognition site for NotI (Psel1) or a
sequence complementary to the end of the CH1 domain and
part of the following intron of the human IgG1 heavy chain
(Psel5). A DNA fragment encoding for genomic human IgG1
(19), encompassing the end of the CH1 domain up to and
including the complete CH3 domain was PCR-amplified from
plasmid 94y4.7HHB by using primers HG1CH1 (GTG GAC
AAG AAA GTT GGT GAG AGG CC) and HG1CH3.NOT
(GCT TGG CGG CCG CCG CAC TCA TTT ACC CGG
AGA CAG). Both fragments were gel-purified and subse-
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quently assembled by gene splicing by overlap extension PCR
(20) using primers Psel1 and HG1CH3.NOT. The assembled
P-selectinyIgG fragment was restricted with NotI and sub-
cloned into the mammalian expression vector pcDNAIyneo
(Invitrogen) to produce vector P6CRhg1.neo. The sequence of
the P-selectin portion up to and including the sixth CR domain
was verified by DNA sequencing.
CHO-K1 cells, maintained in MEMa (GIBCO) with 5%
fetal bovine serum, were seeded overnight in 6-well plates and
transfected with 4 mg of P6CRhg1.neo by using Lipofectamine
(GIBCO) according to the manufacturer’s instructions. Cells
were trypsinized and plated in three 96-well plates. After 24 hr,
0.5 mgyml of G418 (GIBCO) was added for selection, and
media were changed every few days. After 3–4 weeks the plates
were checked for P-selectinyIgG production by using a human
IgG ELISA (21). Cells from high-producing wells were further
cloned by limiting dilution. In this manner, several P-selectiny
IgG producing clones were obtained. For production, P-selec-
tinyIgG producing clones were grown in T175 flasks including
0.5 mgyml of G418 in the media. Media (30 mlyf lask) were
changed every 24 hr, pooled, and kept at 220°C.
P-selectinyIgG pooled cell supernatants were filtered and
concentrated by using a YM100 membrane (Amicon). The
concentrated supernatant was applied on a protein A Sepha-
rose column (Pharmacia) and eluted by using the MAPS II
buffer system (Bio-Rad). The pH of the eluate was quickly
adjusted to pH 8 by the addition of 1 M TriszHCl, pH 8.7. The
eluate from the protein A column was concentrated on a
YM100 membrane and dialyzed overnight against 20 mM
TriszHCl, pH 7.4. The solution then was loaded on a Mono Q
HR10y10 column (Pharmacia), equilibrated with the same
buffer, and eluted with a linear gradient to 1 M NaCl. Mono
Q column fractions were analyzed by SDSyPAGE, pooled,
concentrated, dialyzed against PBS, and stored at 220°C.
For labeling with biotin, P-selectinyIgG was diluted to 0.1
mgyml in 100 mM borate buffer, pH 9.0, 100 mM NaCl. For
every 1 mg of P-selectinyIgG, 20 ml of a 10 mgyml dimethyl
sulfoxide solution of N-(1)-biotinyl-6-aminocaproic acid N-
succinimidyl ester (Fluka) was added to the solution. After a
4-hr incubation at room temperature on a rotating shaker, the
unreacted biotin activated ester was quenched by the addition
of 0.5 ml of 1 M TriszHCl, pH 8.7. After concentration on a
YM100 membrane, the solution was dialyzed against PBS,
aliquoted, and stored at 220°C.
Construction of PSGL-1yIgG Chimera. The complete
cDNA for PSGL-1 was amplified by PCR from a HL-60 cDNA
library. The PSGL-1 cDNA in pBluescript KS1 (Stratgene)
was sequenced in its entirety. A single point mutation (A for
G) at position 77 of the coding region of PSGL-1 was detected.
Correction of the point mutation was performed by using the
Chameleon Double-Stranded, Site-Directed Mutagenesis Kit
(Stratagene) according to instructions. Sequencing of the
resulting vector PSGL-1cor.ksp showed that the insert was
identical to the published PSGL-1 sequence (3). For the
construction of a carboxy-terminal IgG fusion of PSGL-1 we
used an in-frame HincII recognition sequence located at
position 942 of the published PSGL-1 cDNA sequence. An
additional HincII site located in the multiple cloning site of
PSGL-1cor.ksp was removed by restriction with XhoI and SalI
and subsequent religation with T4 DNA ligase.
To allow insertion of desired fusion partners, we created the
expression vector hum-cG1.neoI, which contains a cDNA copy
encoding for a modified human IgG1 heavy chain, where valine
at the carboxyl-terminal end of the CH1 region is replaced with
isoleucine by the addition of an in-frame EcoRV recognition
sequence. Vector hum-cG1.neoI was constructed by PCR
amplification of the modified human IgG1 cDNA sequence
with primers GGA TCC GAT ATC GAC AAG AAA GTT
GAG CCC AAA TC and GGT GCT TGG CGG CCG CCG
CAC TCA TTT ACC CGG AGA CAG by using first-strand
cDNA obtained from mRNA of E-selectinyIgG producing
cells (21) and subcloning the EcoRV- and NotI-restricted
0.72-bp DNA fragment into expression vector pcDNAIyneo
(Invitrogen) cut with the same enzymes.
For the construction of a PSGL-1yIgG chimera expression
vector, a 0.93-kb HindIII and HincII restricted DNA fragment
was excised from modified PSGL1cor.ksp and subcloned into
HindIII and EcoRV restricted vector hum-cG1.neoI. This
vector, designated PSGL1hG1.neoI, contains an insert encod-
ing for a fusion protein of the extracellular portion of human
PSGL-1 up to and including valine-295 and a modified human
IgG1 heavy chain.
Expression vector PSGL1hg1.hyg, allowing hygromycin se-
lection of transfectants, was constructed by transfer of a
1.66-kb HindIIIyXhoI-restricted DNA fragment containing
the entire PSGL-1yIgG coding region from PSGL1hG1.neoI
into HindIIIyXhoI-restricted pcDNA(1).hyg. Expression vec-
tor pcDNA(1).hyg was constructed by inserting into the single
NheI restriction endonuclease site present in pcDNAIyAmp
(Invitrogen) a XbaI-restricted 1.68-kb DNA fragment encom-
passing the entire expression unit for hygromycin-B resistance.
The fragment was obtained from vector pREP7 (Invitrogen)
by PCR amplification by using primers Hyg1.Xba (GCT CTA
GAG CGT TTG CTG GCG GTG TCC) and Hyg2.Xba (GCT
CTA GAC CAT GGG TCT GTC TGC TCA GTC CA). In
pcDNA(1).hyg both the hygromycin-B resistance gene and
inserted genesycDNAs are transcribed in the same direction.
Expression and Purification of PSGL-1 Chimera. The com-
plete cDNA of FTIII in vector pcDM7 (9), from J. Lowe
(University of Michigan, Ann Arbor), was excised by using
XhoI and subcloned into pcDNAIyneo (Invitrogen) to create
the expression vector FT3.neo. Wild-type 293 cells seeded
overnight in a 6-well plate were transfected with 4 mg of
FT3.neo by using Lipofectamine. After 24 hr, cells were
trypsinized into a T175 flask, and 0.5 mgyml of G418 was
added in the media. After selection for 4 weeks, cells were
sorted by using the antibody CSLEX (Becton Dickinson). The
high sLex-expressing cells were cultured for an additional 4
weeks, resorted, and cloned by using limiting dilution. Indi-
vidual clones were analyzed by Fluorescence Assisted Cell
Sorting by using CSLEX, and the highest sLex-expressing clone
(293yFTIII) was used for production of PSGL-1yIgG.
For the construction of cell lines permanently producing
PSGL-1yIgG, wild-type 293 or 293yFTIII cells were seeded
FIG. 1. Schematic representation of selectin-ligand interaction
during leukocyte rolling on venular endothelium and in AFM exper-
iments. The approach and retraction of the AFM sensor simulates the
physiological rolling process. After binding, the force on the complex
increases continuously with increasing sensor-surface distance. After
rupture, the chain-like molecules shrink to their equilibrium length,
and their binding sites, both located close to the amino-terminal ends
of the molecules, are separated.
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overnight in 6-well plates and transfected with 4 mg of
PSGL1hg1.hyg by using Lipofectamine. Cells were trypsinized
into three 96-well plates, and 0.2 mgyml of hygromycin was
added in the media after 24 hr. After 4–5 weeks, wells were
checked for the production of human IgG by using a human
IgG ELISA (21). Clones were obtained by limiting dilution
from wells with high levels of human IgG. Cells subsequently
were maintained in selection antibiotic containing media.
Clones producing PSGL-1 (293yPSGL-1 and 293yFTIIIy
PSGL-1) were seeded in a hollow fiber cartridge (BR110,
UniSyn, Tustin, CA) and maintained in a Cell-Pharm 1000
(UniSyn Technologies). MEMa with selection antibiotics was
used for the circulation media, and the media inside the
cartridge contained 10% ultra-low IgG fetal bovine serum.
Media was harvested from the cartridge every 48 hr. After the
first week of culture, selection antibiotics were withdrawn from
the circulating media. PSGL-1yIgG was purified from pooled
cell supernatants as indicated above for P-selectinyIgG. Puri-
fied PSGL-1yIgG was biotinylated as described above for
P-selectinyIgG.
ELISA Assays. Maxisorb assay plates (Nunc) were coated
with 0.1 ml of P-selectinyIgG (4 mgyml in PBS, overnight at
4°C) and then blocked with 0.25 ml of 2% BSA in PBS for 2
hr at room temperature. Wells then were incubated with
various amounts of PSGL-1yIgG-biotin in 0.1 ml of ELISA
buffer (TriszHCl, pH 7.4 containing 100 mM NaCl, 2 mM
CaCl2 including 0.05% Tween 20 and 0.5% BSA) for 45 min
at room temperature. After washing three times with wash
buffer (TriszHCl, pH 7.4 containing 100 mM NaCl, 2 mM
CaCl2 including 0.05% Tween 20), the plates were incubated
with 0.1 ml of 1y5,000 dilution avidinyhorseradish peroxidase
(Jackson ImmunoResearch) in ELISA buffer for an additional
45 min. Plates then were washed six times with wash buffer,
developed with 0.1 ml of 3,39,5,59-tetramethylbenzidine solu-
tion (Sigma) for 10 min and stopped with 0.05 ml of 1 M
H2SO4.
Plasmon Resonance. Experiments were performed on a
BIAcore 2000 (Pharmacia Biosensor) at 20°C and a constant
flow rate of 5 mlymin. The buffer used was TriszHCl, pH 7.4
containing 100 mM NaCl, 2 mM CaCl2 (assay buffer) including
0.05% Tween 20. Biotinylated PSGL-1yIgG was captured on
a sensor chip SA5 containing immobilized streptavidin on its
surface. For each experimental cycle, a defined concentration
of P-selectinyIgG was injected for 10 min, followed by a 10-min
dissociation phase, where only buffer was passed over the
surface. Regeneration of the PSGL-1yIgG surface was done
with 10 mM glycycrhinic acid in assay buffer, a known inhibitor
of the P-selectinyPSGL-1 interaction (22). Data were analyzed
by using the BIAevaluation program (V2.1; Pharmacia Bio-
sensor).
AFM. Standard glass coverslips and Si3N4 AFM sensors
were silanized with mercaptomethyl-dimethyl-ethoxysilane
(ABCR, Karlsruhe, Germany) in gas phase at 50°C and
subsequently incubated with avidin for 2 hr (2 mgyml in PBS,
pH 7, Sigma). The sensor was incubated with an excess of
biotinylated PSGL-1yIgG and the coverslip with an excess of
biotinylated P-selectinyIgG for 2 hr. The remaining free
binding sites of the unreacted avidin were blocked by subse-
quently incubating both surfaces with biotin for 1 hr (1 mgyml
in PBS, pH 7, Sigma). A Nanoscope III Multimode AFM
(Digital Instruments, Santa Barbara, CA) fitted with a liquid
cell containing assay buffer was used for measurements. For
negative controls, the assay buffer was supplemented with 5
mM EDTA instead of 2 mM Ca21.
The spring constants of the Si3N4 AFM sensors are specified
to about flever 5 0.06 N m21 (Digital Instruments). The
presented data were obtained by two different sensors with
spring constants of 0.064 N m21 and 0.058 N m21 with an
accuracy of 15%. These values have been determined by
measuring the individual sensor geometry by optical micros-
copy (length and width) and white light interferometry (thick-
ness) (23) and verified by a careful analysis of the power
spectrum density of the thermal fluctuations of the cantilevers
(24). The minimum force Fdet, which can be detected by such
a sensor is about 15 pN (Fdet5 (kBTzflever)1/2). During contact
between AFM tip and surface of up to 40 ms, the maximum
compressive force was limited to 500 pN. Approach and pulling
velocities were identical in all experiments and varied from 200
nm s21 to 4,000 nm s21.
RESULTS AND DISCUSSION
PSGL-1 produced in FTIII-transfected 293 cells contains high
amounts of sLex (data not shown) and binds to P-selectin with
high affinity, whereas PSGL-1 produced in wild-type 293 cells
contains no detectable sLex and does not bind to P-selectin
(Fig. 2a). As measured by ELISA, recombinant PSGL-1, under
equilibrium (nonflow) conditions, exhibits a binding constant
of 60 nM for P-selectin (Fig. 2b), coinciding with the 100 nM
reported for the natural P-selectinyPSGL-1 interaction (25).
The kinetic rates of the P-selectinyPSGL-1 interaction were
determined by plasmon resonance with a kon 5 (4 6 2) 3 105
M21 s21 and an apparent koffapp 5 (3 6 1) 3 1024 s21. In these
experiments no external forces are present, and molecular
mobility is only diffusion limited. Therefore, the off-rate is
dominated by avidity effects (26) and may be considered only
as a lower limit of an intrinsic molecular off-rate.
For AFM measurements, P-selectin and PSGL-1 were im-
mobilized on glass coverslips and Si3N4 AFM tips, respectively,
and probed in Ca21 containing assay buffer. The dependence
of the observed adhesion between AFM tip and surface on the
formation of P-selectinyPSGL-1 complexes was verified by two
controls, both of which are standard controls for the physio-
FIG. 2. Binding of recombinant PSGL-1 to P-selectin. (a) ELISA
format assay of PSGL-1yIgG-biotin binding to P-selectinyIgG-coated
plates, showing the dependence of binding on fucosylation with the
tetrasaccheride sLex. The production of fucosylated and nonfucosy-
lated PSGL-1yIgG is described in Materials and Methods. (b) Inhibi-
tion curve by using a constant amount of PSGL-1yIgG-biotin and
variable amounts of PSGL-1yIgG as inhibitors in the same ELISA
assay to determine the binding constant. (c) An overlay of sensorgrams
from plasmon resonance experiments used for determination of
kinetic rate constants. The indicated amount of P-selectinyIgG was
injected over the sensor surface with captured biotinylated PSGL-1y
IgG. During the following dissociation phase of 10 min only buffer was
injected over the sensor surface. As a control, the highest P-selectiny
IgG concentration was passed over the sensor surface with captured
nonfucosylated PSGL-1yIgG.
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logical selectin interaction. Binding could always be abolished
by removing Ca21 and adding EDTA to the assay buffer. The
same tipysurface combination showed again normal binding
events when the assay solution was replaced again with Ca21
containing assay buffer. Additionally, in three independent
experiments, tips functionalized with inactive PSGL-1yIgG
produced in wild-type 293 cells, and therefore lacking sLex,
showed no adhesion events to a P-selectin functionalized
surface. This finding is in agreement to the ELISA results (see
Fig. 2). Rupture forces at specific pulling velocities always
displayed a single peak distribution (see Fig. 3), implying the
rupture of a single P-selectinyPSGL-1 complex and excluding
a statistically distributed simultaneous rupture of several com-
plexes. Measurements were reproducible over hours and typ-
ically for more than 1,000 approach-retract cycles, indicating a
proper fixation of the molecules to their surface via multiple
biotin-avidin bonds in parallel. This indication is supported by
the fact that IgG antibodies reacted with excess biotin under
conditions similar to those used here are on the average
modified with 10 biotin moieties per antibody (27).
Molecular Elasticity. Typical AFM force-distance curves
are shown in Fig. 4a. Upon stretching a molecular complex by
increasing the distance between the AFM sensor and surface
(see Fig. 1), the intramolecular forces were found to increase
nonlinearly as it is typical for a chain-like system (16). The
elasticity of such a system can be described by different models
of polymer elasticity (28). A modified freely jointed chain
(FJC) model (29) describes well the force–extension relation
of the complex in the high and low force regime. It accounts
not only for the entropic elasticity of a molecular chain but also
for the intrinsic enthalpic elasticity of the complex, which could
be stretched over its equilibrium contour length, e.g., Fig. 4a.
The modified FJC model can be described by:
Ex~F! 5 FcothSF z2pkBT D 2 S kBTF z2pDG zFLcontour 1 FfmolecularG ,
where kB, T, p, fmolecular, and Lcontour, respectively denote
Boltzmann constant, temperature, persistence length, molec-
ular spring constant, and molecular contour length.
Fig. 4b shows a fit of a typical force curve to the FJC model
with Lcontour 5 (100 6 5) nm, fmolecular 5 (5.3 6 1.5) pN nm21
and p 5 (0.35 6 0.05) nm. Here, the equilibrium contour
length of the recombinant molecules was calculated with
P-selectin 5 27 nm (25), PSGL-1 5 50 nm (30), IgG frag-
ment 5 5 nm, and biotinyavidin complex 5 5 nm. This
calculation leads to a contour length of the whole complex of
about 97 nm. The molecular spring constant corresponds to the
slope of the force extension curve at large extensions just
before rupture. A direct correlation between the obtained
persistence length and the molecular structure is not straight-
forward because of the heterogeneous proteinycarbohydrate
composition of the complex. But in comparison to other
molecular systems, the P-selectinyPSGL-1 complex exhibits a
persistence length similar to that of cell adhesion proteogly-
cans (16), dextran (14), or a titin Ig domain (15) and a
molecular spring constant comparable with that of a single-
stranded DNA of 100 nm length (30).
Rupture Forces. As can be deduced from Fig. 4a, the rupture
forces have no constant value but continuously increase with
increasing pulling velocity (see Fig. 5) up to values of 165 pN.
This force value is below the estimated maximum force that
can be sustained by P-selectinyPSGL-1 complexes when teth-
ering neutrophils under flow conditions (31–33). But, com-
pared with other AFM experiments, 165 pN is significantly
higher than typical antigenyantibody binding forces of about 60
pN (12). The variation of rupture forces with pulling velocity
is consistent with recent theoretical considerations (17). Upon
modeling the rupture process of an individual complex as a
random event, the dependence of rupture forces on pulling
velocity can be described by a Monte-Carlo simulation (15).
For every successive short time interval (Dt 5 0.1 ms) of the
stretching process, the actual force F(Ex(t)) was calculated via
the FJC model by using the time-dependent extension Ex(t) 5
vpullzt, where vpull denotes the pulling velocity. By calculating
the off-rate according to koff(F) 5 koff0 exp(2F(t)zspotykBT)
(15, 17), the probability of a rupture of the binding at a specific
FIG. 3. (a) Histogram of 584 rupture force values of P-selectiny
PSGL-1 complexes obtained from AFM experiments at a pulling
velocity of 2,800 nm s21. It shows a single peak distribution with a mean
rupture force of 159 pN and a SD of 30 pN. The width of the
distribution reflects the stochastic nature of the rupture process. (b)
Histogram of 600 rupture forces from a Monte-Carlo simulation of the
experiment in a showing a mean rupture force of (168 6 23) pN (for
details see text).
FIG. 4. (a) Force-distance curves between an AFM sensor carrying
PSGL-1 and a P-selectin functionalized surface. Curves at slow and
fast pulling velocity, with multiple adhesion events (seen in less than
15% of curves) and with no adhesion (from top to bottom). Force
values below the baseline correspond to tensile forces in the complex
by retracting the AFM sensor (from left to right) until the binding
ruptures and the sensor snaps back to its equilibrium position (see Fig.
1). (b) Fit of the force-extension relation of a P-selectinyPSGL-1
complex according to a model of molecular elasticity (modified FJC
model, see text).
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force was determined by Prupture 5 koff(F)zDt. The status of the
binding for every time interval was determined by comparing
the rupture probability with the probability obtained from a
random number generator (Ppoll). In case of Ppoll , Prupture, the
actual force is defined as the rupture force of the complex at
given pulling velocity. These calculated rupture forces at
different pulling velocities were fitted to the experimentally
determined rupture forces (see Fig. 5).
From such a fit an off-rate koff0 5 0.022 s21 at zero external
force and a mean width of the P-selectinyPSGL-1 binding
potential spot 5 0.25 nm was determined. By using these
parameters and a pulling velocity of 2,800 nm s21 for a Monte
Carlo simulation, the distribution of rupture forces is in good
agreement with the experimental distribution (Fig. 3). It is
worth noting that rolling experiments with beads or cells can
be described only in terms of a constant force over time and
cannot account for the force dynamics of stretching processes.
These experiments probably result in underestimation of spot
and overestimation of koff0 (32). In contrast, the results from
AFM experiments presented here take the detailed force per
unit time relation and the stochastic nature of single molecule
interaction events into account.
Adhesion Probability. Another characteristic of the P-se-
lectinyPSGL-1 binding, relevant to its biological function, was
found by investigating the dependence of the adhesion prob-
ability between AFM tip and surface on the pulling velocity.
The adhesion probability Padhesion is defined as the ratio
between the number of force curves showing an adhesion event
to the total number of curves. Interestingly, the adhesion
probability in the P-selectinyPSGL-1 system increases with
faster pulling velocities (Fig. 6, Inset). This phenomenon may
be a general feature of selectinyligand interactions and seems
to be the underlying molecular property of the increase in
leukocyte tethering probability with increased shear flow
observed in L-selectin rolling experiments (34). In contrast,
AFM experiments with biotin-avidin, antigen-antibody, or cell
adhesion proteoglycans have shown a constant adhesion prob-
ability that is independent of pulling velocity (10–13).
In general, the adhesive interaction of an AFM tip to a surface
depending on a specific biomolecular reaction can be described
by the differential equation dPadhesion(t)ydt 5 2krupture Padhesion(t)
1 kbind [1 2 Padhesion(t)], where Padhesion(t) denotes the prob-
ability of an adhesion event between AFM tip and surface
during retraction. krupture and kbind are the molecular rupture
and binding rate of the interaction under AFM conditions.
krupture directly corresponds to a forced off-rate koff, and kbind
can be converted into an on-rate via an effective concentration
according to kbind 5 konzceff(d). The effective concentration ceff
describes the number of binding partners within the intersec-
tion volume of the accessible space for molecules on the AFM
tip and on the surface and depends on the distance (d) between
both. Because our system has a very fast on-rate and shows
adhesion probabilities up to nearly 100% at fast pulling
velocities, the binding is considered to be instantaneously
initiated by contact between tip and surface. A rebinding after
rupture of the stretched complex is inhibited because the
molecules shrink to their equilibrium length and their binding
sites are separated (see Fig. 1). Therefore, immediately after
rupture, ceff equals zero. The above-mentioned differential
equation can be simplified for the P-selectinyPSGL-1 interac-
tion in AFM experiments according to dPadhesion(t)ydt 5 2koff
Padhesion(t). By using the boundary condition Padhesion (t 5 0) 5
1 the instantaneous binding at contact between tip and surface
is taken into account and the missing kbind term accounts for
the inhibited rebinding.
To describe its kinetics, a time scale of the AFM experiment
has to be estimated. As can be calculated by the FJC model,
forces in the complex during the first 60 nm of its extension are
below the AFM detection limit of about 15 pN. Therefore, a
rupture event can be detected only after a certain interaction
time tint 5 sdetyvpull, defined by the distance traveled by the tip
(sdet) after contact to this 15 pN detection limit divided by the
pulling velocity (vpull). Consequently, the slower the pulling
velocity the more time a complex has to unbind without being
stretched significantly, leading to a decrease of observable
adhesion events with longer interaction times (see Fig. 6).
Using this timescale, the velocity dependence of the adhesion
probability of a P-selectinyPSGL-1 complex can be converted
into a time-dependent adhesion probability. It can be de-
scribed as a first-order exponential decay according to the
simplified differential equation (see above) with an off-rate of
koff 5 (15 6 2) s21. This fast off-rate accounts for a ‘‘forced’’
unbinding process under the externally applied forces of the
AFM experiment.
Energetics. The kinetic and mechanical data can be directly
compared by estimating the energies involved. The unforced
binding constant KD 5 koff0ykon 5 55 nM, obtained from the
Monte Carlo simulation (koff0) and plasmon resonance (kon),
FIG. 5. Dependence of P-selectinyPSGL-1 rupture forces on AFM
pulling velocity. Each data point represents a Gaussian fit to about 50
rupture force values. The error bars correspond to the SD of the
rupture force distribution in Fig. 3. (Inset) The experimental rupture
forces (data points) show a logarithmic dependence on pulling velocity
and can be modeled by a Monte-Carlo simulation of the unbinding
process (straight line, for details see text).
FIG. 6. The time-dependent adhesion probability between a P-
selectin functionalized surface and a PSGL-1-activated AFM tip
reflects the fast forced off-rate of the P-selectinyPSGL-1 binding. The
interaction time was varied upon changing the AFM pulling velocity
(Inset). Each data point represents 30 approach-retraction cycles. The
decrease in adhesion probability after long interaction times corre-
sponds to a lifetime of the complex in the AFM experiment of about
70 ms.
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is consistent with the equilibrium binding constant of 60 nM
from ELISA and corresponds to a binding energy of 41 kJ
mol21. The energy required to change the off-rate koff 5 koff0
exp(DGykBT) from the unforced to the forced value is 16 kJ
mol21. As can be calculated by integrating the force-extension
function this energy is considerably smaller than the mechan-
ical energy of 200 kJ mol21 required to stretch a complex
during the interaction time. This finding indicates that most of
the mechanical energy is absorbed by working against the
thermal motion of the chain-like P-selectinyPSGL-1 complex
and only a fraction of the mechanical energy influences the
binding kinetics. This fraction, however, is sufficient to ac-
count for the three orders of magnitude change from unforced
to forced off-rates.
CONCLUSIONS
We have shown that the rupture of an adhesive interaction
between single molecules can be well described by a stochastic,
nondeterministic process. Description of a receptoryligand
binding strength either in terms of kinetics or from a purely
mechanical point of view is incomplete, because both are
coupled via the time dependence of the involved forces.
Therefore, the rupture of a receptoryligand complex can occur
at variable forces and lifetimes, either by resting a long time at
small forces or within a short time under high forces. Our
Monte-Carlo simulation shows that rupture forces are mainly
influenced by the off-rate of the receptor ligand interaction. As
a consequence longer lifetimes of a complex should cause
higher rupture forces. The on-rate seems to have no influence
on rupture forces but can influence the adhesion probability.
Therefore, rupture processes and forces are not adequately
described by a thermodynamic equilibrium constant but by a
kinetic rate constant. In general, changes in adhesion proba-
bilities and forces in AFM experiments with pulling velocity
are expected for interactions where the kinetic rate constants
are on a time scale comparable to that of AFM experiments of
about milliseconds to minutes.
Previous studies on selectin systems did not allow the direct
determination of force, distance, and time parameters of single
binding events. Although in the AFM experiment the adhesion
molecules are immobilized on a hard surface instead of
anchored in a cell membrane, this setup allows determination
of their intrinsic molecular properties that are the basis for the
physiological rolling process. Compared with other ligandy
receptor systems studied under external forces the P-selectiny
PSGL-1 system exhibits a fast forced off-rate and a high
chain-like elasticity. Even at small extensions entropic forces of
thermal motion accelerate the unbinding of the complex. After
rupture the molecules immediately shrink to their equilibrium
length and their binding sites separate. The physical separation
prevents a rebinding of the same complex and can explain why
selectins are not able to mediate firm adhesion of leukocytes
to endothelium (31, 33). Furthermore, the weak logarithmic
dependence of the molecular binding forces on pulling velocity
(see Fig. 5) can explain the weak dependence of leukocyte
rolling velocities on flow rates (35). The long contour length
of the complex together with its high molecular elasticity
reduces the mechanical loading on the receptoryligand binding
and allow leukocyte rolling even at high shear rates.
Leukocyte rolling is a good example of how the mechanical
properties of single molecules determine the characteristics of
cell-cell adhesion. Here we show that such processes do not
depend only on solution affinities, but are also strongly influ-
enced by mechanical stability, applied forces, and topology at
the molecular level. Molecular probing techniques, such as
AFM, provide the opportunity to manipulate and investigate
single molecules or cells and obtain crucial information about
adhesion processes not obtainable by solution methods.
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